Kurtzhals, Peter http://orcid.org/0000-0003-0392-1000
Østergaard, Søren http://orcid.org/0000-0002-9415-3352
Nishimura, Erica http://orcid.org/0000-0001-5741-3648
Kjeldsen, Thomas http://orcid.org/0000-0003-0094-9286
Article History
Accepted: 29 June 2022
First Online: 24 August 2022
Competing interests
: All authors are employees and shareholders of Novo Nordisk A/S. T.K. is co-inventor of insulin analogues, which are described in the following patents: WO2009/115469, US Patent 9,035,020 B1 and WO2015/128403 A2. S.O. is co-inventor of peptide YY (PYY) analogues which are described in US Patent US2015/0152150 A1.